ES2228648T3 - Protesis ortopedica. - Google Patents
Protesis ortopedica.Info
- Publication number
- ES2228648T3 ES2228648T3 ES00986404T ES00986404T ES2228648T3 ES 2228648 T3 ES2228648 T3 ES 2228648T3 ES 00986404 T ES00986404 T ES 00986404T ES 00986404 T ES00986404 T ES 00986404T ES 2228648 T3 ES2228648 T3 ES 2228648T3
- Authority
- ES
- Spain
- Prior art keywords
- bioabsorbable
- layer
- adhesive
- prosthesis
- surface opposite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000000399 orthopedic effect Effects 0.000 title claims description 12
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 54
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 54
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 50
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 49
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 49
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims abstract description 49
- 239000000853 adhesive Substances 0.000 claims abstract description 38
- 230000001070 adhesive effect Effects 0.000 claims abstract description 38
- 238000000034 method Methods 0.000 claims abstract description 18
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 54
- 229920000954 Polyglycolide Polymers 0.000 claims description 19
- 239000004743 Polypropylene Substances 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 17
- -1 polypropylene Polymers 0.000 claims description 17
- 229920001155 polypropylene Polymers 0.000 claims description 17
- 210000001835 viscera Anatomy 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 13
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 12
- 239000004626 polylactic acid Substances 0.000 claims description 12
- 239000011148 porous material Substances 0.000 claims description 12
- 229920001577 copolymer Polymers 0.000 claims description 8
- 239000004633 polyglycolic acid Substances 0.000 claims description 8
- 229920001610 polycaprolactone Polymers 0.000 claims description 7
- 238000003825 pressing Methods 0.000 claims description 6
- 239000004632 polycaprolactone Substances 0.000 claims description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 3
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 claims description 2
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims description 2
- 239000000622 polydioxanone Substances 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920000903 polyhydroxyalkanoate Polymers 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 150000003672 ureas Chemical class 0.000 abstract 1
- 239000006260 foam Substances 0.000 description 26
- 229920000339 Marlex Polymers 0.000 description 8
- 229920006362 Teflon® Polymers 0.000 description 8
- 230000003902 lesion Effects 0.000 description 7
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 206010019909 Hernia Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 238000003475 lamination Methods 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 239000008259 solid foam Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QMGYPNKICQJHLN-UHFFFAOYSA-M Carboxymethylcellulose cellulose carboxymethyl ether Chemical compound [Na+].CC([O-])=O.OCC(O)C(O)C(O)C(O)C=O QMGYPNKICQJHLN-UHFFFAOYSA-M 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 206010021620 Incisional hernias Diseases 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000002747 omentum Anatomy 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000001139 rectus abdominis Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L31/129—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing macromolecular fillers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46669799A | 1999-12-17 | 1999-12-17 | |
| US466697 | 1999-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2228648T3 true ES2228648T3 (es) | 2005-04-16 |
Family
ID=23852752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES00986404T Expired - Lifetime ES2228648T3 (es) | 1999-12-17 | 2000-12-14 | Protesis ortopedica. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20030100955A1 (de) |
| EP (1) | EP1237588B1 (de) |
| JP (1) | JP2003516816A (de) |
| AT (1) | ATE283715T1 (de) |
| AU (1) | AU2264801A (de) |
| CA (1) | CA2393354A1 (de) |
| DE (1) | DE60016455T2 (de) |
| ES (1) | ES2228648T3 (de) |
| IL (1) | IL149800A0 (de) |
| PT (1) | PT1237588E (de) |
| WO (1) | WO2001043789A1 (de) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040267349A1 (en) * | 2003-06-27 | 2004-12-30 | Kobi Richter | Amorphous metal alloy medical devices |
| US8382821B2 (en) | 1998-12-03 | 2013-02-26 | Medinol Ltd. | Helical hybrid stent |
| US7404819B1 (en) | 2000-09-14 | 2008-07-29 | C.R. Bard, Inc. | Implantable prosthesis |
| DE10155842A1 (de) | 2001-11-14 | 2003-05-28 | Ethicon Gmbh | Flächiges Implantat |
| DE10222872B4 (de) | 2002-05-23 | 2018-08-16 | Johnson & Johnson Medical Gmbh | Medizinisches Implantat und Verfahren zum Herstellen eines medizinischen Implantats |
| FR2840801B1 (fr) * | 2002-06-18 | 2005-06-03 | Cie De Rech En Composants Impl | Implant prothetique composite |
| DE10318801A1 (de) * | 2003-04-17 | 2004-11-04 | Aesculap Ag & Co. Kg | Flächiges Implantat und seine Verwendung in der Chirurgie |
| FR2856305B1 (fr) | 2003-06-19 | 2007-08-24 | Inst Nat Sante Rech Med | Protheses avec revetements biologiquement actifs |
| DE10353930A1 (de) * | 2003-07-18 | 2005-02-03 | Feg Textiltechnik | Textiles Intraperitoneal-Mesh |
| US20050113849A1 (en) * | 2003-11-26 | 2005-05-26 | Nicholas Popadiuk | Prosthetic repair device |
| US20050182443A1 (en) | 2004-02-18 | 2005-08-18 | Closure Medical Corporation | Adhesive-containing wound closure device and method |
| CA2563347C (en) | 2004-04-20 | 2014-01-14 | Genzyme Corporation | Surgical mesh-like implant |
| US20060009099A1 (en) | 2004-07-12 | 2006-01-12 | Closure Medical Corporation | Adhesive-containing wound closure device and method |
| US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| WO2006036984A2 (en) | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Stand-alone film and methods for making the same |
| US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US9278161B2 (en) * | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
| US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
| DE102006033218B4 (de) * | 2006-07-13 | 2011-11-10 | Biocer Entwicklungs Gmbh | Modifiziertes künstliches Gewebe, Verfahren zu dessen Herstellung und dessen Verwendung |
| US7614258B2 (en) | 2006-10-19 | 2009-11-10 | C.R. Bard, Inc. | Prosthetic repair fabric |
| ES2387583T3 (es) * | 2007-10-19 | 2012-09-26 | Stryker Trauma Gmbh | Sustituto de hueso sintético, procedimiento para preparar el mismo y procedimiento para rellenar una cavidad en un sustrato |
| US8206632B2 (en) * | 2007-12-18 | 2012-06-26 | Ethicon, Inc. | Methods of making composite prosthetic devices having improved bond strength |
| US20090163936A1 (en) * | 2007-12-21 | 2009-06-25 | Chunlin Yang | Coated Tissue Engineering Scaffold |
| US20100082113A1 (en) * | 2008-04-29 | 2010-04-01 | Peter Gingras | Tissue repair implant |
| US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
| FR2949688B1 (fr) * | 2009-09-04 | 2012-08-24 | Sofradim Production | Tissu avec picots revetu d'une couche microporeuse bioresorbable |
| US8758798B2 (en) * | 2010-03-24 | 2014-06-24 | Covidien Lp | Therapeutic implant |
| US8821585B2 (en) * | 2010-06-14 | 2014-09-02 | Ethicon, Inc. | Composite anisotropic tissue reinforcing implants having alignment markers and methods of manufacturing same |
| US9211175B2 (en) * | 2010-07-08 | 2015-12-15 | Covidien Lp | Self-detachable medical devices |
| WO2012009707A2 (en) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
| US8579990B2 (en) | 2011-03-30 | 2013-11-12 | Ethicon, Inc. | Tissue repair devices of rapid therapeutic absorbency |
| TWI561535B (en) | 2011-10-06 | 2016-12-11 | Bvw Holding Ag | Copolymers of hydrophobic and hydrophilic segments that reduce protein adsorption |
| KR101461652B1 (ko) * | 2011-12-16 | 2014-11-21 | 주식회사 삼양바이오팜 | 유착방지용 조성물, 이를 포함하는 유착방지기능을 갖는 수술용 메쉬 복합체 및 이의 제조 방법 |
| RU2687275C2 (ru) * | 2013-02-01 | 2019-05-13 | Аллерган, Инк. | Слезозаменитель, содержащий гиалуронат натрия и карбоксиметилцеллюлозу |
| EP3062740A4 (de) * | 2013-11-01 | 2017-08-02 | Atrium Medical Corporation | Positionierungsmittel und verfahren zur verwendung davon |
| EP3132927B1 (de) * | 2014-03-31 | 2020-05-06 | Toray Industries, Inc. | Mehrschichtfolie, integrierte folie damit und herstellungsverfahren dafür |
| US10786980B2 (en) | 2014-06-18 | 2020-09-29 | Toray Industries, Inc. | Laminate and production method therefor |
| DE102015013989A1 (de) * | 2015-10-30 | 2017-05-04 | Johnson & Johnson Medical Gmbh | Chirurgisches Implantat |
| US20170368230A1 (en) * | 2016-06-23 | 2017-12-28 | Dermagenesis, Llc | Matrix construction |
| US10792024B2 (en) | 2016-09-28 | 2020-10-06 | Ethicon, Inc. | Scaffolds with channels for joining layers of tissue at discrete points |
| USD848624S1 (en) | 2016-09-29 | 2019-05-14 | Ethicon, Inc. | Release paper for wound treatment devices |
| US10687986B2 (en) | 2016-09-29 | 2020-06-23 | Ethicon, Inc. | Methods and devices for skin closure |
| US10470935B2 (en) | 2017-03-23 | 2019-11-12 | Ethicon, Inc. | Skin closure systems and devices of improved flexibility and stretchability for bendable joints |
| US20180271505A1 (en) | 2017-03-23 | 2018-09-27 | Ethicon, Inc. | Scaffolds for Joining Layers of Tissue at Discrete Points |
| US11504446B2 (en) | 2017-04-25 | 2022-11-22 | Ethicon, Inc. | Skin closure devices with self-forming exudate drainage channels |
| US10993708B2 (en) | 2018-07-31 | 2021-05-04 | Ethicon, Inc. | Skin closure devices with interrupted closure |
| US12478488B2 (en) | 2020-02-19 | 2025-11-25 | Medinol Ltd. | Helical stent with enhanced crimping |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5017229A (en) | 1990-06-25 | 1991-05-21 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
| US5632979A (en) * | 1988-05-31 | 1997-05-27 | University Of Florida Research Foundation, Inc. | Method and composition for preventing surgical adhesions |
| US6294202B1 (en) * | 1994-10-06 | 2001-09-25 | Genzyme Corporation | Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers |
| US5989535A (en) * | 1997-08-15 | 1999-11-23 | Soma Technologies | Polymeric bioadhesive emulsions and suspensions and methods of treatment |
| WO2000016822A1 (en) * | 1998-09-21 | 2000-03-30 | The Brigham And Women's Hospital, Inc. | Compositions and methods for tissue repair |
-
2000
- 2000-12-14 DE DE60016455T patent/DE60016455T2/de not_active Expired - Fee Related
- 2000-12-14 AT AT00986404T patent/ATE283715T1/de not_active IP Right Cessation
- 2000-12-14 EP EP00986404A patent/EP1237588B1/de not_active Expired - Lifetime
- 2000-12-14 ES ES00986404T patent/ES2228648T3/es not_active Expired - Lifetime
- 2000-12-14 CA CA002393354A patent/CA2393354A1/en not_active Abandoned
- 2000-12-14 JP JP2001544925A patent/JP2003516816A/ja not_active Withdrawn
- 2000-12-14 PT PT00986404T patent/PT1237588E/pt unknown
- 2000-12-14 IL IL14980000A patent/IL149800A0/xx unknown
- 2000-12-14 AU AU22648/01A patent/AU2264801A/en not_active Abandoned
- 2000-12-14 WO PCT/US2000/033971 patent/WO2001043789A1/en not_active Ceased
-
2003
- 2003-01-13 US US10/341,121 patent/US20030100955A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003516816A (ja) | 2003-05-20 |
| EP1237588B1 (de) | 2004-12-01 |
| PT1237588E (pt) | 2005-03-31 |
| DE60016455T2 (de) | 2005-12-15 |
| AU2264801A (en) | 2001-06-25 |
| WO2001043789A1 (en) | 2001-06-21 |
| CA2393354A1 (en) | 2001-06-21 |
| US20030100955A1 (en) | 2003-05-29 |
| EP1237588A1 (de) | 2002-09-11 |
| IL149800A0 (en) | 2002-11-10 |
| DE60016455D1 (de) | 2005-01-05 |
| ATE283715T1 (de) | 2004-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2228648T3 (es) | Protesis ortopedica. | |
| ES2402435T3 (es) | Dispositivo de reparación de tejido con un miembro de soporte bioabsorbible | |
| ES2626126T3 (es) | Dispositivo de colágeno y procedimiento de preparación del mismo | |
| EP1738780B1 (de) | Bioimplantierbarer Collagenträger | |
| ES2549062T3 (es) | Implante para ensanchar la válvula nasal, bioabsorbible y con múltiples capas | |
| ES2289403T3 (es) | Protesis implantable. | |
| KR100895135B1 (ko) | 생분해성 및 난분해성 영역을 갖는 수술용 보철물 | |
| US20080071300A1 (en) | Prosthetic repair device | |
| US20110307077A1 (en) | Composite anisotropic tissue reinforcing implants having alignment markers and methods of manufacturing same | |
| JP2011200653A (ja) | 治療用移植片 | |
| JP2011200652A (ja) | 治療用移植片 | |
| CN117563042A (zh) | 包括编织物和非多孔膜的合成修复体以及用于形成该修复体的方法 | |
| ES2438491T3 (es) | Dispositivo implantable que comprende un sustrato pre-recubierto con fibrina estabilizada | |
| Nathanson et al. | Histologic response to porous PMMA implant materials | |
| SU904693A1 (ru) | Протез сосуда | |
| US20060095139A1 (en) | Composite prosthetic implant | |
| JP2016517298A (ja) | 単一面組織修復パッチ | |
| CN108348317A (zh) | 外科植入物 | |
| ES2578907T3 (es) | Dispositivo bioimplantable de colageno | |
| AU2013202206B2 (en) | Composite anisotropic tissue reinforcing implants having alignment markers and methods of manufacturing same |